Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales

Shares of Bausch Health Companies Inc. (BHC) gained 2.36% after the company reported better-than-expected fourth-quarter results. Shares also gained 7.8% in aftermarket trading.Adjusted earnings per share of $1.15 beat the Zacks Consensus Estimate of$1.12. The earnings were flat year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Total revenues of $2.56 billion were up 6% year over year. The top line also beat the Zacks Consensus Estimate by 1.89%.Excluding the impact of f ...